How to Store KGF: Stability and Handling, Per the Research

Keratinocyte growth factor (KGF), also called fibroblast growth factor 7 (FGF-7), is a protein in the fibroblast growth factor family that signals through the FGFR2b receptor on epithelial cells. A related family member, KGF-2 (FGF-10), was the subject of a 2023 expression paper describing high-level production of keratinocyte growth factor 2 in Escherichia coli (PMID 36641112). Because KGF is a folded protein rather than a short synthetic chain, the storage questions that surround it are protein-formulation questions: how a lyophilized cake behaves versus a solution, how temperature and agitation affect folded structure, and how a laboratory confirms that the molecule is still biologically intact.

This page is for educational purposes only and is not medical advice; consult a licensed physician or qualified healthcare professional for any question about a specific product, formulation or clinical situation. Nothing here is a handling instruction, and no preparation or dosing procedure is described.

What the Verified Literature Does — and Does Not — Cover

An honest storage page has to start by labelling its sources. Among the KGF papers reviewed for this page, none was a stability study. A 2019 study reported that KGF induced podosome formation in human immortalized oral epithelial cells through integrin–Erk1/2 signalling (PMID 31082464), which is a signalling-biology result rather than a shelf-life result. A 2019 materials paper reported that fibrin nanoparticles coupled with KGF enhanced the dermal wound-healing rate (PMID 30604611), which speaks to delivery and carrier design rather than storage temperature. And the 2023 E. coli paper addressed upstream production and purification of KGF-2 (PMID 36641112), not how purified material behaves over months in a vial.

Everything in the sections below that is not tied to one of those citations is general protein and lyophilized-peptide stability science — principles that apply across recombinant proteins and are reflected in cold-chain labelling for approved biologics — and it is flagged as such. It is not KGF-specific measured data, and it should not be read as though a trial had established those numbers for KGF.

Refrigeration: Lyophilized Powder Versus Reconstituted Solution

Lyophilized (freeze-dried) material

General formulation science, not KGF-specific study data: freeze-drying removes the bulk water that drives hydrolysis, deamidation and microbial growth, which is why recombinant proteins are commonly supplied as a dry cake with bulking agents and stabilisers such as sugars, polyols or amino acids. In that dry state, the dominant degradation routes slow dramatically, and refrigerated storage in the conventional 2–8 °C cold-chain band is the standard condition described for lyophilized protein biologics. Light protection and an intact stopper seal are part of the same general picture, because residual moisture ingress and photo-oxidation of aromatic residues are recognised failure modes for dry protein powders.

Once in solution

General formulation science: reconstitution restores water, and with it the chemical pathways that lyophilization was designed to suppress. Solutions of recombinant growth factors are typically assigned much shorter handling windows than the dry powder — hours to a small number of days under refrigeration is the pattern seen in biologic labelling, rather than the months-to-years assigned to the sealed lyophilized vial. Adsorption to glass and plastic surfaces is an additional, often underappreciated loss route for dilute protein solutions, which is why carrier proteins or surfactants appear in many research buffers.

Regulatory reference point

Palifermin, a recombinant human KGF, is an approved product in the United States for oral mucositis in specific haematology settings, and it is supplied as a lyophilized powder whose labelling specifies refrigerated storage with protection from light and a limited hold time once reconstituted. That is a regulatory and labelling fact about one finished drug product, not a generalisable stability measurement for research-grade KGF preparations, which differ in sequence truncation, formulation buffer and excipients. Research-use-only material carries no approved labelling at all.

Shelf Life and Expiry Dating

General science: an expiry date on a protein product is not a prediction about a specific vial; it is the end of the interval over which the manufacturer's own stability programme demonstrated that the material still met its specifications under the stated storage condition. Those programmes combine real-time storage at the labelled temperature with accelerated studies at elevated temperatures, and they track potency, purity, aggregate content and appearance. Nothing in the KGF literature reviewed here reported such a dataset; the 2023 production paper stopped at high-level expression and purification of KGF-2 in E. coli (PMID 36641112) without extending into long-term storage characterisation.

Two consequences follow. First, a dating period that appears on a research-grade KGF vial is a supplier claim, and the supporting stability data may or may not exist in any published form. Second, expiry dating is condition-specific: a date derived from refrigerated storage says nothing about a vial that spent a week in a warm room. The label condition and the date are a single package.

Room Temperature and Travel

General science: temperature excursions matter far more for proteins in solution than for sealed dry powder, because reaction rates in the aqueous phase rise sharply with temperature while a low-moisture glassy cake is comparatively inert. Shipping practice for lyophilized biologics reflects this: dry product often travels with cold packs as a precaution rather than because brief ambient exposure is known to destroy it, whereas liquid biologics are shipped under validated cold chain with temperature monitoring.

Mechanical stress is the other travel variable that general protein science emphasises. Shaking and vigorous agitation create air–liquid interfaces where folded proteins unfold and aggregate, and repeated pressure changes in air transport can add to that stress. Aggregation is relevant to KGF specifically because the assays that demonstrate its activity depend on correctly folded, receptor-competent protein: the 2019 oral epithelial cell work reported that KGF drove podosome formation via integrin–Erk1/2 signalling (PMID 31082464), a response that would not be expected from denatured or aggregated material.

Freezing and Freeze–Thaw

General science: freezing is commonly used for long-term storage of purified protein solutions, but the act of freezing and thawing is itself a stress. Ice formation concentrates solutes in the remaining liquid phase, shifts pH as buffer components crystallise at different rates, and creates ice–water interfaces at which proteins can unfold. The standard mitigation described in protein-handling literature is single-use aliquoting, so that each thaw exposes material only once, together with cryoprotective excipients such as sugars or polyols in the formulation.

For a sealed lyophilized cake, freezing is generally unnecessary rather than harmful: the dry state already suppresses the hydrolytic pathways that freezing is meant to arrest, and condensation on a cold vial brought into a humid room introduces moisture, which is one of the main enemies of a freeze-dried powder. None of these points was measured on KGF in the papers cited here; they are cross-protein principles.

Signs of Degradation: What Studies Report

No study in this citation set characterised KGF degradation products or defined visual failure criteria for KGF vials. What analytical protein chemistry describes generally is that a compromised lyophilized cake may show collapse, shrinkage, melt-back or discoloration relative to a uniform white cake, and that a reconstituted protein solution may show haze, visible particulates, fibres or a gel-like phase when aggregation has occurred. Difficulty dissolving a cake that previously dissolved readily is another general flag, since aggregation reduces solubility.

Crucially, appearance is a coarse screen, not a potency assay. Substantial loss of biological activity can occur in a solution that still looks clear, which is why laboratories assess growth-factor integrity with functional readouts rather than by eye. In the KGF literature, researchers used cell-based responses for exactly that purpose: the 2019 study reported KGF-induced podosome formation in human immortalized oral epithelial cells (PMID 31082464), and a separate 2019 report evaluated KGF coupled to fibrin nanoparticles and reported an enhanced dermal wound-healing rate (PMID 30604611). Functional endpoints of that kind, not visual inspection, are what demonstrate that a KGF preparation is still doing what KGF does.

Formulation and Carrier: A Storage Variable in Its Own Right

Growth factors are frequently reformulated to extend their useful life at the site of action, and that engineering also changes their handling profile. The 2019 nanoparticle study reported that KGF coupled to fibrin nanoparticles enhanced the dermal wound-healing rate (PMID 30604611), illustrating that KGF is often studied as part of a delivery system rather than as bare protein in buffer. Upstream, the 2023 paper on high-level production of KGF-2 in E. coli described the expression and purification route that determines what excipients and residual process components accompany the final protein (PMID 36641112). Two vials labelled "KGF" from different processes are therefore not interchangeable for stability purposes: buffer, pH, stabiliser content and aggregation state all differ.

Limits of This Evidence

• No KGF shelf-life, freeze–thaw or accelerated-degradation study appears in the verified citation set; the KGF papers here addressed signalling (PMID 31082464), delivery (PMID 30604611) and production (PMID 36641112).
• General lyophilized-protein principles are mechanistic and cross-molecular; they do not supply numbers for any particular KGF preparation.
• Approved-product labelling describes one specific finished formulation under defined conditions and does not transfer to research-grade material.
• Storage conditions interact with formulation, container closure and handling history, so published conditions for one product are not a general rule.

Readers looking for background on what KGF is and what its research literature covers can see the overview at /learn/kgf/, and the cross-compound stability principles discussed here are treated in more depth at /guides/how-to-store-peptides/.

References

• Keratinocyte growth factor (KGF) induces podosome formation via integrin-Erk1/2 signaling in human immortalized oral epithelial cells (Cellular Signalling, 2019)
• Fibrin Nanoparticles Coupled with Keratinocyte Growth Factor Enhance the Dermal Wound-Healing Rate (ACS Applied Materials & Interfaces, 2019)
• High-level production of keratinocyte growth factor 2 in Escherichia coli (Protein Expression and Purification, 2023)